University Hospitals Case Medical Center to test gammaglobulin treatment for Alzheimer's disease

Researchers from the Memory and Cognition Center at University Hospitals Case Medical Center will begin testing an intriguing new approach to slowing down the progression of Alzheimer's Disease (AD) using Intravenous Immune Globulin (IGIV), also known as gammaglobulin.

Read the whole article on Science Blog

More from Science Blog